The groundbreaking rise of Viagra has firmly established as a example of pharmaceutical success, but its future within the broader industry now raises questions about potential gains. Copycat versions are diminishing exclusivity , causing worries that betting on companies heavily reliant to Viagra's once-dominant influence could be a problematic st